Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Underwood, Mark A; Umberger, Erin; Patel, Ravi M.

Pediatr Res ; 88(Suppl 1): 48-55, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32855513

2.

Grading the evidence to identify strategies to modify risk for necrotizing enterocolitis.

Gephart, Sheila M; Underwood, Mark A; Rosito, Simone; Kim, Jae H; Caplan, Michael S.

Pediatr Res ; 88(Suppl 1): 41-47, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32855512

3.

The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.

Wedgwood, Stephen; Warford, Cris; Agvatisiri, Sharleen R; Thai, Phung N; Chiamvimonvat, Nipavan; Kalanetra, Karen M; Lakshminrusimha, Satyan; Steinhorn, Robin H; Mills, David A; Underwood, Mark A.

Pediatr Res ; 87(3): 472-479, 2020 02.

Artículo en Inglés | MEDLINE | ID: mdl-31537010

4.

Neonatal Vitamin A Supplementation and Vitamin A Status Are Associated with Gut Microbiome Composition in Bangladeshi Infants in Early Infancy and at 2 Years of Age.

Huda, M Nazmul; Ahmad, Shaikh M; Kalanetra, Karen M; Taft, Diana H; Alam, Md J; Khanam, Afsana; Raqib, Rubhana; Underwood, Mark A; Mills, David A; Stephensen, Charles B.

J Nutr ; 149(6): 1075-1088, 2019 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-31006815

5.

Arguments for routine administration of probiotics for NEC prevention.

Underwood, Mark A.

Curr Opin Pediatr ; 31(2): 188-194, 2019 04.

Artículo en Inglés | MEDLINE | ID: mdl-30664022

6.

Should we treat every infant with a probiotic?

Underwood, Mark A.

Minerva Pediatr ; 71(3): 253-262, 2019 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-31017382

7.

Bifidobacterium infantis, Necrotizing Enterocolitis, Death, and the Role of Parents in the Neonatal Intensive Care Unit.

Underwood, Mark A.

J Pediatr ; 244: 14-16, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35151680

8.

Validating bifidobacterial species and subspecies identity in commercial probiotic products.

Lewis, Zachery T; Shani, Guy; Masarweh, Chad F; Popovic, Mina; Frese, Steve A; Sela, David A; Underwood, Mark A; Mills, David A.

Pediatr Res ; 79(3): 445-52, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-26571226

9.

Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.

Powell, Weston T; Borghese, Robyn A; Kalanetra, Karen M; Mirmiran, Majid; Mills, David A; Underwood, Mark A.

J Pediatr Gastroenterol Nutr ; 62(6): 852-857, 2016 06.

Artículo en Inglés | MEDLINE | ID: mdl-26545203

10.

Infant Maturity at Birth Reveals Minor Differences in the Maternal Milk Metabolome in the First Month of Lactation.

Spevacek, Ann R; Smilowitz, Jennifer T; Chin, Elizabeth L; Underwood, Mark A; German, J Bruce; Slupsky, Carolyn M.

J Nutr ; 145(8): 1698-708, 2015 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-26041675

11.

Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes.

Caplan, Michael S; Underwood, Mark A; Modi, Neena; Patel, Ravi; Gordon, Phillip V; Sylvester, Karl G; McElroy, Steven; Manzoni, Paolo; Gephart, Sheila; Chwals, Walter J; Turner, Mark A; Davis, Jonathan M.

J Pediatr ; 212: 208-215.e1, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31235383

12.

Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota.

Underwood, Mark A; Arriola, Jennifer; Gerber, Colin W; Kaveti, Ashwini; Kalanetra, Karen M; Kananurak, Anchasa; Bevins, Charles L; Mills, David A; Dvorak, Bohuslav.

Pediatr Res ; 76(4): 326-33, 2014 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-25000347

13.

Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses.

Underwood, Mark A; Kananurak, Anchasa; Coursodon, Christine F; Adkins-Reick, Camille K; Chu, Hiutung; Bennett, Stephen H; Wehkamp, Jan; Castillo, Patricia A; Leonard, Brian C; Tancredi, Daniel J; Sherman, Michael P; Dvorak, Bohuslav; Bevins, Charles L.

Pediatr Res ; 71(5): 546-51, 2012 May.

Artículo en Inglés | MEDLINE | ID: mdl-22322385

14.

Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.

Prabhakaran, Jaya; Arango, Victoria; Majo, Vattoly J; Simpson, Norman R; Kassir, Suham A; Underwood, Mark D; Polavarapu, Hanish; Bruce, Jeffrey N; Canoll, Peter; Mann, J John; Kumar, J S Dileep.

Bioorg Med Chem Lett ; 22(15): 5104-7, 2012 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-22749281

15.

Necrotizing enterocolitis.

Lin, Hung-Chih; Wu, Shu-Fen; Underwood, Mark.

N Engl J Med ; 364(19): 1878-9; author reply 1879, 2011 05 12.

Artículo en Inglés | MEDLINE | ID: mdl-21568003

16.

Probiotics and Human Milk Oligosaccharides in Premature Infants.

Underwood, Mark A.

Neoreviews ; 20(1): e1-e11, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-31261069

17.

Probiotics and the prevention of necrotizing enterocolitis.

Underwood, Mark A.

J Pediatr Surg ; 54(3): 405-412, 2019 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-30241961

18.

Probiotic mechanisms of action.

Halloran, Katrina; Underwood, Mark A.

Early Hum Dev ; 135: 58-65, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31174927

19.

Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis.

Marcobal, Angela; Underwood, Mark A; Mills, David A.

J Pediatr Gastroenterol Nutr ; 46(5): 608-11, 2008 May.

Artículo en Inglés | MEDLINE | ID: mdl-18493222

20.

Probiotics and necrotizing enterocolitis.

Patel, Ravi Mangal; Underwood, Mark A.

Semin Pediatr Surg ; 27(1): 39-46, 2018 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-29275816

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Grading the evidence to identify strategies to modify risk for necrotizing enterocolitis.

The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.

Neonatal Vitamin A Supplementation and Vitamin A Status Are Associated with Gut Microbiome Composition in Bangladeshi Infants in Early Infancy and at 2 Years of Age.

Arguments for routine administration of probiotics for NEC prevention.

Should we treat every infant with a probiotic?

Bifidobacterium infantis, Necrotizing Enterocolitis, Death, and the Role of Parents in the Neonatal Intensive Care Unit.

Validating bifidobacterial species and subspecies identity in commercial probiotic products.

Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.

Infant Maturity at Birth Reveals Minor Differences in the Maternal Milk Metabolome in the First Month of Lactation.

Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes.

Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota.

Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses.

Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.

Necrotizing enterocolitis.

Probiotics and Human Milk Oligosaccharides in Premature Infants.

Probiotics and the prevention of necrotizing enterocolitis.

Probiotic mechanisms of action.

Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis.

Probiotics and necrotizing enterocolitis.